CHDR Annual Report 2023
Contents 2023
  • Homepage
  • 2023 in perspective
  • Developing drugs
  • Developing methods
  • Developing people
  • 2023 stories
Other years

Developing drugs

CHDR’s research groups made vital contributions to the development of new drugs in 2023. In this we are proud to collaborate with a range of valued clients and partners, some of whom also share their stories below.

Lancet publication: novel malaria drug suitable for prophylaxis

'Curiosity is one of our company's core values, and I'm glad to see it here at CHDR, too' — Dr Karl Hansen, Praxis Precision Medicines

The adventurous journey of an immunological compound

Small steps towards effective treatments in neurodegenerative disorders

'The spirit of the collaboration has been good' — Dr Heikki Mansikka, Orion Pharma

Recruited: patients with the right degree of knee osteoarthritis

'We ask ourselves: what would give us confidence to take the next step?' - Dr Fabienne Schumacher, Sanofi

Sensitivity to light flashes used in antiepileptic drug development

Painkiller aimed at promising target now studied in phase III trial

Reducing respiratory depression without affecting anaesthesia

Back to homepage
  • © CHDR 2026
  • +31 (0)71 5246400
  • info@chdr.nl
  • www.chdr.nl